Therapy News and Research

RSS

Early intervention may be crucial to successful treatment of Friedreich's ataxia

New research published today in Disease Models & Mechanisms indicates that early intervention should be a key target in the development of new therapeutics for Friedreich's ataxia, as current treatments may be administered too late to target the disease effectively.

8 Nov 2017

UNIGE neuroscientists succeed in correcting activity of late neurons

During the fetal stage, millions of neurons are born in the walls of the ventricles of the brain before migrating to their final location in the cerebral cortex.

8 Nov 2017

New category of immunotherapy appears safe to use in patients with both cancer and HIV

A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many different cancers appears safe to use in patients with both advanced malignancies and HIV, a population excluded from earlier trials of such therapies, according to an early-phase trial.

7 Nov 2017

Stem cells could help improve blood circulation in diabetic patients with peripheral artery disease

Stem cells taken from muscle tissue could promote better blood flow in patients with diabetes who develop peripheral artery disease, a painful complication that can require surgery or lead to amputation.

7 Nov 2017

Australia’s annual report on STIs shows increasing rates of gonorrhea and syphilis

Cases of gonorrhea and syphilis are increasing in Australia, according to the most recent Annual Surveillance Report on HIV, viral hepatitis and sexually transmissible infections (STIs) in Australia.

7 Nov 2017

Popular Alzheimer's drug shows promise in clinical trials for treating patients with sickle cell disease

A popular drug commonly used to treat Alzheimer's disease has shown promise in laboratory and clinical trials for treating patients with sickle cell disease (SCD).

7 Nov 2017

High protein diet may have deleterious long-term impact on kidney health

High protein diets may lead to long-term kidney damage among those suffering from chronic kidney disease, according to research led by nephrologist Kamyar Kalantar-Zadeh, MD, MPH, PhD, of the University of California, Irvine.

7 Nov 2017

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Research at the Southwest National Primate Research Center on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

7 Nov 2017

Researchers to test use of ‘viral specific’ T-cells to target toxic viruses in children

Michael Pulsipher, MD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, along with Michael Keller, MD from Children's National Health System in Washington, DC, have been awarded $4.8 million by the California Institute for Regenerative Medicine to study the use of a new T-cell therapy to help fight active viral infections in children with severe immune deficiencies.

7 Nov 2017

FDA approves first targeted cancer treatment based on basket study

The US Food and Drug Administration has announced that it has approved the drug vemurafenib for the treatment of patients with BRAF V600-mutant Erdheim-Chester disease (ECD).

7 Nov 2017

FDA grants approval to first treatment for rare blood cancer

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.

7 Nov 2017

Common antidepressants may not work for depressed patients with chronic kidney disease

Scientists are finding more evidence that commonly prescribed antidepressants aren't effective in people battling both depression and a chronic medical disease, raising a critical question of whether doctors should enact widespread changes in how they treat millions of depressed Americans.

7 Nov 2017

FDA approves new drug Zelboraf for Erdheim-Chester disease

The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.

6 Nov 2017

ORBITA trial on heart stents for stable angina indicates placebo effect potential

A new study conducted by researchers at the Imperial College London suggests that the placebo effect experienced by patients who receive coronary artery stents might be larger than expected, even though stents themselves are life-saving.

6 Nov 2017

Poor social skills may negatively affect physical and mental health

Those who struggle in social situations may be at greater risk for mental and physical health problems, according to a new study from the University of Arizona.

6 Nov 2017

Researchers discover how traffic jam in intracellular sorting can cause tumor development

For tissues to cooperate and perform normal functions, cells need to know which way is up. When cells lose track of their orientation, they can start to grow out of control, and develop into cancer.

6 Nov 2017

Art therapy facilitates improvement of patients with severe depression

Create a picture of how you are feeling on this particular day, said the first exercise in the art therapy. After ten treatments the patients who suffered from severe or moderately severe depression had shown more improvement than the patients in the control group, shows research at Sahlgrenska academy.

6 Nov 2017

Biologics do not raise risk of second cancer diagnosis in RA patients

Treatment with biologics does not increase the risk of a second malignancy in rheumatoid arthritis patients who have a history of cancer, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting.

6 Nov 2017

Study shows link between use of reflux medications and increased risk of CKD, kidney failure

A recent analysis has linked certain medications commonly used to treat heartburn, acid reflux, and ulcers with the development of kidney disease. The findings will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.

6 Nov 2017

$Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women$

Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women

Women who took a drug holiday (temporary or permanent discontinuation of a medicine) from using bisphosphonates for more than two years have a significantly higher risk of a hip fracture compared to others who continued their treatment, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

6 Nov 2017

Therapy News and Research

Early intervention may be crucial to successful treatment of Friedreich's ataxia

UNIGE neuroscientists succeed in correcting activity of late neurons

New category of immunotherapy appears safe to use in patients with both cancer and HIV

Stem cells could help improve blood circulation in diabetic patients with peripheral artery disease

Australia’s annual report on STIs shows increasing rates of gonorrhea and syphilis

Popular Alzheimer's drug shows promise in clinical trials for treating patients with sickle cell disease

High protein diet may have deleterious long-term impact on kidney health

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Researchers to test use of ‘viral specific’ T-cells to target toxic viruses in children

FDA approves first targeted cancer treatment based on basket study

FDA grants approval to first treatment for rare blood cancer

Common antidepressants may not work for depressed patients with chronic kidney disease

FDA approves new drug Zelboraf for Erdheim-Chester disease

ORBITA trial on heart stents for stable angina indicates placebo effect potential

Poor social skills may negatively affect physical and mental health

Researchers discover how traffic jam in intracellular sorting can cause tumor development

Art therapy facilitates improvement of patients with severe depression

Biologics do not raise risk of second cancer diagnosis in RA patients

Study shows link between use of reflux medications and increased risk of CKD, kidney failure

Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News